The company, which has ties to Marty Makary, President Donald Trumps pick to lead the FDA, also said its working with manufacturers to secure deeper discounts on the medications in late 2025 and into 2026
What weve seen in a real-world setting is those who discontinue particularly early and patients who stay on lower maintenance dosages are quite unlikely to see the weight reductions that are reported in randomized trials
Even after licensing, NHS access would depend on guidance, indications, local pathways and, in many cases, broader health-system decisions rather than approval alone
Rekha Kumar, endocrinologist and associate professor of clinical medicine at Weill Cornell, told NBC's Anne Thompson during an Oct
This complete guide compares every brand, breaks down the science, and reveals why Hymeys Whitening Serum at PKR 1,750 outperforms every standalone glutathione serum in Pakistan